Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis

Figure 1 Improvements in liver histology at week 240 of entecavir treatment in patients (n = 38) with paired liver biopsies (baseline and week 240). A: Distribution of Knodell necroinflammatory scores at baseline and at week 240; B: Distribution of Ishak fibrosis scores at baseline and at week 240.